NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/05/2025
Voltar para busca
Dado oficial do USPTO
LENTIHERO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
07/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
23/09/2022
Data de registro
06/05/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/05/2025
Última transação
07/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Comberton, Cambridge, GB
Examinador
KLUWE, CHERYL
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ASTREA UK SERVICES LIMITED
Representantes
Ben Natter HAUG PARTNERS, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Polymeric nanofiber filtering compositions for viral particle purificationother than for medical or veterinary purposes; polymeric nanofiber filtering materials for virus-like particle purificationother than for medical or veterinary purposes; polymeric nanofiber filtering compositions for viral vector purificationother than for medical or veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor viral particlevirus-like particle and viral vector purification of chemical and biological substancesother than for medical or veterinary purposes; chromatographic media for purification of viral particlesvirus-like particles and viral vectors other than for medical or veterinary purposes; filtering media consisting of chemicals and biologicals for chromatographic purification of substances comprising of chemicals and biologicalsother than for medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and virus-like particles for viral vector developmentother than for medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsother than for medical or veterinary purposes; chemicals and biologicals for use in bioseparation for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; chemicals and biologicals for use in filtering for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; chemical and biological substances for use in separation for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; fibres of inorganic polymeric material for separation purposes for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; fibres of organic polymeric material for separation purposes for viral particlevirus-like particle and viral vector purificationother than for medical or veterinary purposes; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial usereagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemicalsantibodies and antibody fragments for in vitro scientific or research use
Classe 5
Proteins for medical diagnostic purposes; enzymes for medical and medical diagnostic use; viral particlesvirus-like particles and viral vectors for medical use; proteinsnamely polypeptides for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues; Polymeric nanofiber filtering compositions for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; polymeric nanofiber filtering materials for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor viral particle virus-like particle and viral vector purification of chemical and biological substancesfor medical or veterinary purposes; chromatographic media for purification of viral particlesvirus-like particles and viral vectors for medical or veterinary purposes; filtering media consisting of chemicals and biologicals for chromatographic purification of substances comprising of chemicals and biologicalsfor medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and viral -like particles for viral vector developmentfor medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsfor medical or veterinary purposes; chemicals and biologicals for use in bioseparation for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; chemicals and biologicals for use in filtering for viral particlevirus-like particle and viral vector purificationfor medical or veterinary purposes; chemical and biological substances for use in separation for viral particle virus-like particle and viral vector purificationfor medical or veterinary purposes; fibres of inorganic polymeric material for separation purposes for viral particle virus-like particle and viral vector purificationfor medical or veterinary purposes; fibres of organic polymeric material for separation purposes for viral particlevirus-like particle purificationfor medical or veterinary purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/03/2025
PUBO
PUBLISHED FOR OPPOSITION
18/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/02/2025
EXPT
EXPARTE APPEAL TERMINATED
21/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/01/2025
EXPI
EX PARTE APPEAL-INSTITUTED
24/01/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
24/01/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
24/01/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
22/10/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
22/10/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
26/07/2024
GNFR
FINAL REFUSAL E-MAILED
26/07/2024
CNFR
FINAL REFUSAL WRITTEN
26/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2024
ALIE
ASSIGNED TO LIE
07/03/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
18/10/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
16/10/2023
CNSL
SUSPENSION LETTER WRITTEN
16/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/07/2023
GNRT
NON-FINAL ACTION E-MAILED
14/07/2023
CNRT
NON-FINAL ACTION WRITTEN
14/07/2023
DOCK
ASSIGNED TO EXAMINER
24/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2022
NWAP
NEW APPLICATION ENTERED
27/09/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LENTIHERO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.